Yogesh Kumar Chawla

The President, Shri Pranab Mukherjee presenting the Padma Shri Award to Dr. Yogesh Chawla, at a Civil Investiture Ceremony, at Rashtrapati Bhavan, in New Delhi on 8 April 2015 Yogesh Kumar Chawla is an Indian medical doctor, hepatologist and has served as the director of the Post Graduate Institute of Medical Education and Research (PGIMER), Chandigarh. He graduated in medicine from the Netaji Subhash Chandra Bose Medical College, Jabalpur, secured a master's degree (MD) in gastroenterology from the same college before joining PGIMER in 1983 as a member of faculty of the department of hepatology and became the head of the department in 1999. Chawla, a recipient of the 1999 Dr. B. C. Roy Award and an elected fellow of the National Academy of Medical Sciences was honoured by the Government of India in 2015 with Padma Shri, the fourth highest Indian civilian award. Provided by Wikipedia
Showing 1 - 3 results of 3 for search 'Yogesh Kumar Chawla', query time: 0.02s Refine Results
  1. 1
    Gastrointestinal and Liver Manifestations of COVID-19

    Gastrointestinal and Liver Manifestations of COVID-19 by Sunil Taneja, Rohit Mehtani, Yogesh Kumar Chawla

    Published 2020-04-01
    Get full text
    Article
  2. 2
    Acute Liver Failure Due to Etodolac, a Selective Cycloxygenase- 2 (COX -2) Inhibitor Non-Steroidal Anti-Inflammatory Drug Established by RUCAM-Based Causality Assessment

    Acute Liver Failure Due to Etodolac, a Selective Cycloxygenase- 2 (COX -2) Inhibitor Non-Steroidal Anti-Inflammatory Drug Established by RUCAM-Based Causality Assessment by Sunil Taneja, Pramod Kumar, Sahaj Rathi, Ajay Duseja, Virendra Singh, Radha Krishan Dhiman, Yogesh Kumar Chawla

    Published 2017-09-01
    Get full text
    Article
  3. 3
    Metformin is effective in achieving biochemical response in patients with nonalcoholic fatty liver disease (NAFLD) not responding to lifestyle interventions** This work was presented at the Asian Pacific Digestive Week at Cebu City, Philippines in November 2006 (J Gastroenterol Hepatol 2006; 21 (suppl 6): A457).

    Metformin is effective in achieving biochemical response in patients with nonalcoholic fatty liver disease (NAFLD) not responding to lifestyle interventions** This work was present... by Ajay Duseja, Ashim Das, Radha Krishan Dhiman, Yogesh Kumar Chawla, Kiran K. Thumburu, Sanjay Bhadada, Anil Bhansali

    Published 2007-10-01
    Get full text
    Article

Search Tools: